Posts

Showing posts with the label Biotechnology Market

Biotechnology Market 2030: Innovations Driving Healthcare Forward

Image
Due to the growing demand for drug discoveries to treat chronic diseases, the biotechnology market has achieved a huge breakthrough in scientific research and development. Biotechnology refers to the use of living organisms or biological systems to develop products that improve human life. It is a combination of biology and technology that contributes significantly to various scientific fields, such as genetics, microbiology, and personalized medicine. Bioinformatics is an application of technology and computer science to analyze and interpret biological data, especially genomic data. The application of biotechnology in bioinformatics is revolutionizing science and healthcare by helping researchers understand complex biological systems. It has led to new treatments and advancements in medicine. One of the primary contributions of biotechnology to bioinformatics is the generation of large-scale biological data. Technologies such as next-generation sequencing (NGS) have allowed scient...

Biotechnology Market Competitive Scenario, Opportunities, Development Status By 2030

Image
Biotechnology Industry Overview The global  biotechnology market   size is expected to reach USD 3,879.51 billion by 2030, registering a CAGR of 13.9% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors including the advent of innovative and advanced technologies, significant investments & government initiatives favoring the biotechnology industry, and rising demand for synthetic biology applications. Biotechnology startups are acquiring robust funding support and venture capital investments, which, in 2021, amounted to USD 41 billion; an increase of over 11% as compared to the previous year’s USD 36.7 billion. Notable funding rounds included Caris Life Sciences’ $830 million in May 2021 for its  precision medicine  platform expansion, Abogen’s $700 million Series C funding in August 2021 for its COVID-19 vaccine candidate’s clinical development, & ElevateBio’s $...